Menu Back toAutomation-in-Pharmacovigilance-Doing-More-With-Less

DIA 2018 Global Annual Meeting

Automation in Pharmacovigilance: Doing More With Less

    Session Chair(s)
      Axel  Hagel

      Axel Hagel

      • Partner and Senior Director
      • Foresight, A QuintilesIMS Company, Canada
    The session will provide an overview of the current pharmacovigilance landscape and where the industry stands on automation versus manual processes with respect to adverse event processing, assessing, reporting and signaling. Functional areas will then be presented where companies can employ simple to sophisticated means to automate many of the resource intensive processes that will result in better consistency, higher quality and improved compliance.
    Learning Objective : Identify functions or processes that are candidates for improvement within their own pharmacovigilance practice especially through methods of automation; Explain how companies have successfully automated many aspects of the PV process and the benefits as well as liabilities such an automation can bring.
      Masha  Hoffey, MS

      Data Visualization and Analytics for Medical Monitors: Tech Adoption and Best Practices

      Masha Hoffey, MS

      • Director of Clinical Analytics
      • PerkinElmer Informatics, Inc., United States
      Neal  Grabowski, MS

      Signal Detection in Social Media: Feasibility Assessment of Methods

      Neal Grabowski, MS

      • Signal Management Officer
      • Amgen Inc., United States